Literature DB >> 10912979

Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy.

G W Cundiff1, M T McLennan, A E Bent.   

Abstract

OBJECTIVE: To determine the efficacy of prophylactic nitrofurantoin in preventing bacteriuria after urodynamics and cystourethroscopy.
METHODS: We assumed that nitrofurantoin prophylaxis would decrease the rate of infection after urodynamics and cystourethroscopy from 19% to 5%. All women presenting for urodynamics and cystourethroscopy during a 27-month period were offered enrollment, and 142 were randomly assigned to receive two doses of long-acting nitrofurantoin 100 mg (n = 74), or two doses of placebo (n = 68). Nitrofurantoin and placebo capsules were identical, and subjects and physicians were masked to group assignment. Differences were assessed using Student t test for continuous data and chi2 analysis for dichotomous data.
RESULTS: There were no statistical differences in demographic characteristics or final diagnoses between groups. Seven women (5%) who had bacteriuria on initial urine culture were not included in the final analysis. The frequency of bacteriuria in the postinstrumentation urine cultures was 6% overall, 7% in the treatment group, and 5% in the controls, a nonsignificant difference ([relative risk] 1.49, [confidence interval] 0.37, 5.95). The power of the study was 33% to detect a significant difference.
CONCLUSION: Bacteriuria after combined urodynamics and cystourethroscopy was not improved by a 1-day course of nitrofurantoin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10912979     DOI: 10.1016/s0029-7844(98)00521-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Prophylactic antibiotics after urodynamics in women: a decision analysis.

Authors:  Jerry L Lowder; Lara J Burrows; Nancy L S Howden; Anne M Weber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-04

Review 2.  Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures and review of the literature.

Authors:  Oz Harmanli; Rebecca L Boyer; Stephen Metz; Elena Tunitsky; Keisha A Jones
Journal:  Int Urogynecol J       Date:  2011-07-26       Impact factor: 2.894

3.  Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis.

Authors:  Jonathan P Shepherd; Keisha A Jones; Oz Harmanli
Journal:  Int Urogynecol J       Date:  2013-08-01       Impact factor: 2.894

4.  Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy.

Authors:  Shuxiong Zeng; Zhensheng Zhang; Yu Bai; Yinghao Sun; Chuanliang Xu
Journal:  Cochrane Database Syst Rev       Date:  2019-02-21

5.  Prophylactic antibiotic use in pediatric patients undergoing urinary tract catheterization: a survey of members of the Society for Pediatric Urology.

Authors:  Alexander P Glaser; Ilina Rosoklija; Emilie K Johnson; Elizabeth B Yerkes
Journal:  BMC Urol       Date:  2017-09-06       Impact factor: 2.264

6.  Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?

Authors:  Pawel Miotla; Sara Wawrysiuk; Kurt Naber; Ewa Markut-Miotla; Pawel Skorupski; Katarzyna Skorupska; Tomasz Rechberger
Journal:  Biomed Res Int       Date:  2018-11-05       Impact factor: 3.411

Review 7.  Urodynamic studies for management of urinary incontinence in children and adults.

Authors:  Keiran David Clement; Marie Carmela M Lapitan; Muhammad Imran Omar; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2013-10-29

8.  Prospective evaluation of the efficacy of antibiotic prophylaxis before cystoscopy.

Authors:  Kamil Cam; Ali Kayikci; Ali Erol
Journal:  Indian J Urol       Date:  2009-04

9.  Antibiotic use in urological surgeries: a six years review at Muhimbili National Hospital, Dar es salaam-Tanzania.

Authors:  Obadia Nyongole; Larry Akoko; Ally Mwanga; Mabula Mchembe; Benjamin Kamala; Naboth Mbembati
Journal:  Pan Afr Med J       Date:  2015-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.